CONTROL OF FIBRINOLYSIS DURING PORTACAVAL SHUNTS. STUDY OF PATIENTS WITH CIRRHOSIS OF THE LIVER.
D000347:Afibrinogenemia; D000614:Aminocaproates; D015119:Aminocaproic Acid; D005342:Fibrinolysis; D006801:Humans; D006971:Hypersplenism; D006973:Hypertension; D006975:Hypertension, Portal; D008103:Liver Cirrhosis; D011167:Portacaval Shunt, Surgical; D011183:Postoperative Complications; D011517:Prothrombin Time; D013921:Thrombocytopenia
D000614:Aminocaproates; D015119:Aminocaproic Acid
AFIBRINOGENEMIA; AMINOCAPROIC ACID; FIBRINOLYSIS; HYPERSPLENISM; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; PORTACAVAL ANASTOMOSIS; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN TIME; THROMBOPENIA